Back to top
more

IMV INC (IMV)

(Delayed Data from NSDQ)

$4.40 USD

4.40
93,262

+0.70 (18.92%)

Updated May 3, 2019 04:00 PM ET

After-Market: $4.50 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

IMV Doses First Patient in the Mid-Stage Study With Keytruda

IMV (IMV) doses first patient in the phase II study evaluating lead compound, maveropepimut-S (MVP-S), in combination with Keytruda

Do Options Traders Know Something About IMV Stock We Don't?

Investors need to pay close attention to IMV stock based on the movements in the options market lately.

IMV INC (IMV) Reports Next Week: What to Expect

IMV INC (IMV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IMV Enters Oversold Territory

IMV has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

IMV INC (IMV) Reports Q2 Loss, Lags Revenue Estimates

IMV INC (IMV) delivered earnings and revenue surprises of 25.00% and -42.86%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Should You Buy IMV Ahead of Earnings?

IMV is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

IMV INC (IMV) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

IMV INC (IMV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IMV Inc. (IMV) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in IMV Inc. (IMV).

IMV Catches Eye: Stock Jumps 10%

IMV saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

IMV INC (IMV) Reports Q1 Loss, Tops Revenue Estimates

IMV INC (IMV) delivered earnings and revenue surprises of -27.27% and 27.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate IMV INC (IMV) to Report a Decline in Earnings: What to Look Out for

IMV INC (IMV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sweta Jaiswal, FRM headshot

Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development

The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.

Biotech Stock Roundup: HOTH & IMV to Develop Coronavirus Vaccines, & More

The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.

IMV to Develop Vaccine Candidate Against COVID-19, Shares Up

IMV plans to develop a vaccine candidate using its lipid-based delivery platform, DPX technology, for the treatment of coronavirus disease. Stock rises.

Will IMV INC (IMV) Report Negative Q4 Earnings? What You Should Know

IMV INC (IMV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IMV INC (IMV) Reports Q3 Loss, Tops Revenue Estimates

IMV INC (IMV) delivered earnings and revenue surprises of -33.33% and 175.56%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Will IMV INC (IMV) Report Negative Earnings Next Week? What You Should Know

IMV INC (IMV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate IMV INC (IMV) to Report a Decline in Earnings: What to Look Out for

IMV INC (IMV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.